Is a supplier certificate the same as a batch COA?

No. A certificate describes a qualification or standard. A batch COA records test results and release information for one identified lot.

Should every bulk shipment be accompanied by a batch COA?

For a controlled procurement process, the received lot should be traceable to its own COA and agreed specification. Confirm the documentation package in the quality agreement before ordering.

Bulk Ingredient Documentation Checklist: COA, SDS & Traceability

Short answer

A supplier certificate is not enough on its own. Before approving a bulk bioactive ingredient, match the intended use to an agreed specification, then review the actual lot COA, SDS, packaging and storage statement, and traceability information. The documents should describe the same material and batch—not a generic marketing template.

1. Documents to request before approval

Document	What a buyer should verify
Product specification	Identity, assay basis, relevant impurities, physical requirements, storage, and acceptance limits agreed for the intended market and use.
Batch COA	Lot number, release date, test results, methods or method references, analyst or quality approval, and a match to the physical label.
SDS	Safe handling, transport, storage, and hazard information appropriate to the material and destination.
Analytical-method summary	Method principle, assay basis, reference standard, and whether the method fits the risk being reviewed. A method name alone is not proof of market compliance.
Packaging and storage statement	Inner liner, outer container, protection from moisture/light/temperature, and conditions after opening.
Traceability information	Manufacturing or release date, retest/shelf-life statement, batch code, and a route for handling deviations or complaints.

2. Match the COA to the real batch

The batch code on the COA should match the label and shipping documents. Check whether the result is reported as-is or on a dry basis, whether the test methods fit the agreed specification, and whether a pass result is being compared with the correct limit. For sensitive or high-value projects, procurement teams may also request a method summary, chromatogram, or independent verification under a quality agreement.

3. Quality frameworks are not universal product claims

ICH Q7 describes quality-management expectations for active pharmaceutical ingredient manufacturing, including material and supplier controls. It is a useful risk-based reference for a pharmaceutical project, but it does not automatically make every food, cosmetic, diagnostic, or research raw material an API. Acceptance criteria must be agreed for the actual application and destination market.

4. A practical release checklist

Confirm product name, CAS number or identifier, grade, and intended use.
Compare the actual lot COA against the agreed specification—not against a website headline.
Verify assay, relevant impurities, water or loss on drying, elemental impurities, microbiology, and residual solvents where applicable.
Confirm packaging, storage, shipment route, and temperature protection for the material.
Keep the quotation, quality agreement, COA, and receiving inspection record tied to the same lot.

How PathGene supports project review

PathGene provides current product information and can coordinate available batch and technical documentation for project review. The required document package depends on whether the material is being evaluated for dietary supplements, personal care, enzymatic work, diagnostic-reagent development, or pharmaceutical research. Start from the relevant product page and state the intended use when requesting a quotation or sample.

References

ICH Q7 Questions and Answers; FDA: ICH Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients.

NAD+ & Coenzymes

Bulk Bioactive Ingredient Documentation Checklist: COA, Specification, SDS and Traceability